New Czech anti-cancer treatment will be tested on 60 people around the US and the Czech Republic, the daily Právo reported. The new anti-cancer medicine, developed by Czech scientist Antonín Holý, could be used in the treatment of patients suffering from lymphatic tissue cancer. It has proved very successful in the treatment of tumours when administered to dogs. If the clinical trials on humans prove to be successful, the new medicine might appear on the market within six to eight years. It will be produced by the US Gilead Sciences company.
Country’s leading epidemiologist makes U-turn on strategy of herd immunity
Economist Tomáš Sedláček: A positive look at the coronavirus crisis
Fall in coronavirus reproduction number shows efficacy of strict measures
How is coronavirus affecting Prague’s real estate market?
Czech government loosens restrictions ahead of Easter, but masses and caroling strictly banned